{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 42,
        "end": 50
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 59,
        "end": 69
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 92,
        "end": 96
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 135,
        "end": 139
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 151,
        "end": 155
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "27040858_7",
  "text": "This patient had an excellent response to Icotinib but not crizotinib , suggesting that the EGFR mutation was the oncogenic driver but ROS1 fusion and KRAS mutation not ."
}
